Prophylactic cyclo-oxygenase inhibitor drugs to prevent morbidity and mortality in preterm infants

<p>The Cochrane Neonatal Group is one of the largest Cochrane groups, with more than 400 reviews published, many of which relate to the care of babies born before they reach full-term. These reviews were added to in April 2022 with a new review of the use of cyclo-oxygenase inhibitors and, in this podcast, one of the group’s researchers, Abbey MacLellan, talks with lead author Souvik Mitra, a neonatologist and clinical epidemiologist at Dalhousie University and IWK Health in Halifax Canada about this network meta-analysis.</p>